Evofem Biosciences, Inc. announced that it has appointed Justin J. File as Secretary, effective December 16, 2022. Mr. File currently also serves as the Company's Chief Financial Officer. Justin J. File has served as Private Evofem's Chief Financial Officer from April 2015 until January 2018 and has served as Chief Financial Officer since January 2018.

Mr. File has also served as the Chief Financial Officer of the women's health nonprofit organization WCG Cares from November 2017 to May 2018 He has approximately 28 years of diverse accounting and finance experience within a variety of both public and private biotechnology and biopharmaceutical companies. Most recently, Mr. File provided executive financial and accounting oversight services to various biotechnology companies in San Diego, California, assisting in their initial public offering process and helping to establish and improve their accounting and finance operations as publicly traded entities. Prior to this, Mr. File was Senior Director and Controller of Sequenom, Inc. During that time, Mr. File served as Treasurer of Sequenom's diagnostic subsidiary and provided assistance in the raising of over $400 million in combined equity and convertible note offerings.

Mr. File also assisted in the commercialization of four diagnostic tests in a two-year period, which included Sequenom's revolutionary noninvasive prenatal test for Down syndrome. Earlier in his career Mr. File worked for approximately ten years in public accounting, primarily with Arthur Andersen LLP, where he worked with a variety of clients assisting with attestation and periodic reporting requirements, public offerings and acquisitions. Mr. File graduated from Central Washington University with a Bachelor of Science in Accounting and Business Administration.

He is a Certified Public Accountant (inactive).